Search

Your search keyword '"J. Solski"' showing total 94 results

Search Constraints

Start Over You searched for: Author "J. Solski" Remove constraint Author: "J. Solski"
94 results on '"J. Solski"'

Search Results

1. Influence of Hemodialysis Catecholamine Levels in the Blood Plasma of Patients with Chronic Renal Failure

2. Effect of riluzole (Rilutek) treatment on plasma amino acid percentages in amyotrophic lateral sclerosis patients

3. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain

4. Membrane ATPase, erythrocyte sodium and potassium in haemodialysis patients

5. Noradrenaline turnover in the tissues of uraemic rats

6. Plasma amino acids percentages in amyotrophic lateral sclerosis patients

7. Plasma amino acids concentration in amyotrophic lateral sclerosis patients

9. Sialic acids of young and old red blood cells in healthy subjects

10. Proteolytic enzymes in the treatment of acute pancreatitis

11. Lipid and lipoprotein ratios as risk factors of atherosclerosis in patients with chronic renal insufficiency (CRI)

12. Effect of repeated treatments with cladribine (2-chlorodeoxyadenosine) on blood counts in multiple sclerosis patients

13. Plasma catecholamine concentration and dopamine-beta-hydroxylase activity during haemodialysis with acetate or bicarbonate at different sodium concentrations in hypotensive patients

14. [Effectiveness of peritoneal dialysis using dialysis fluid of modernized composition]

15. Plasma amino acids concentration in amyotrophic lateral sclerosis patients.

16. Sympathetic activity, plasma renin activity (PRA) and kininogen levels in patients haemodialysed with acetate and bicarbonate

17. High and low sodium acetate haemodialysis and ultrafiltration

21. Effect of dialysate sodium on the dopamine, adrenaline and noradrenaline concentration in haemodialysis patients

26. Diagnostic strategies for SARS-CoV-2 infection

27. Analysis of serum homocysteine in the laboratory practice - comparison of the direct chemiluminescence immunoassay and high performance liquid chromatography coupled with fluorescent detection.

28. Fibroblast growth factor 21, epidermal growth factor receptor, interleukin 6, myeloperoxidase, lipid hydroperoxide, apolipoproteins A-I and B, as well as lipid and lipoprotein ratios as diagnostic serum biomarkers for gastric cancer.

29. Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease.

30. Levels of renalase and advanced oxidation protein products with regard to catecholamines in haemodialysed patients.

31. γ-amino butyric acid (GABA) level as an overall survival risk factor in breast cancer.

32. Relationship between microRNA-146a expression and plasma renalase levels in hemodialyzed patients.

33. Role of circulating microRNA in hemodialyzed patients.

34. Fibroblast growth factor 21 - a key player in cardiovascular disorders?

35. Polycystic ovary syndrome: clinical implication in perimenopause.

36. Relationship between renalase and N-terminal pro-B-type natriuretic peptide (NT pro-BNP) in haemodialysis patients.

37. Plasma and erythrocyte relationship of catecholamines in hemodialysis patients.

38. Association between lipids, lipoproteins composition of HDL particles and triglyceride-rich lipoproteins, and LCAT and CETP activity in post-renal transplant patients.

39. Serum fibroblast growth factor 21 is predictive of combined cardiovascular morbidity and mortality in patients with type 2 diabetes at a relatively short-term follow-up.

40. Level of glycation gap in a healthy subject.

41. Association between moderately oxidized low-density lipoprotein and high-density lipoprotein particle subclass distribution in hemodialyzed and post-renal transplant patients.

42. [Evaluation of metabolic control in patients with type 2 diabetes].

43. Evaluation of concentrations of FGF-21 - a new adipocytokine in type 2 diabetes.

44. Effect of parenteral cladribine on relapse rates in patients with relapsing forms of multiple sclerosis: results of a 2-year, double-blind, placebo-controlled, crossover study.

45. Sialic acid content in erythrocyte membranes of patients on chronic hemodialysis.

46. Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients.

47. [Analysis of some risk factors of coronary artery calcification in peritoneal dialysis patients].

48. A long-term study of dyslipidemia and dyslipoproteinemia in stable post-renal transplant patients.

49. [Analysis of early surgical complications after strumectomy].

50. Disturbed lipoprotein composition in non-dialyzed, hemodialysis, continuous ambulatory peritoneal dialysis and post-transplant patients with chronic renal failure.

Catalog

Books, media, physical & digital resources